L-Glutamic acid-13C5,15N

Modify Date: 2024-01-01 23:11:43

L-Glutamic acid-13C5,15N Structure
L-Glutamic acid-13C5,15N structure
Common Name L-Glutamic acid-13C5,15N
CAS Number 202468-31-3 Molecular Weight 153.09
Density N/A Boiling Point N/A
Molecular Formula 13C5H915NO4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of L-Glutamic acid-13C5,15N


L-Glutamic acid-13C5,15N is the 13C- and 15N-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.

 Names

Name L-Glutamic acid-13C5,15N

 L-Glutamic acid-13C5,15N Biological Activity

Description L-Glutamic acid-13C5,15N is the 13C- and 15N-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

 Chemical & Physical Properties

Molecular Formula 13C5H915NO4
Molecular Weight 153.09
Top Suppliers:I want be here


Get all suppliers and price by the below link:

L-Glutamic acid-13C5,15N suppliers

L-Glutamic acid-13C5,15N price

Related Compounds: More...
L-Glutamic acid-13C5,d5,15N
1420815-74-2
L-Glutamic acid-13C5 hydrate salt
202114-62-3
L-Glutamic acid-13C5
55443-55-5
L-Glutamic acid (15N)
21160-87-2
N-(tert-Butoxycarbonyl)-L-glutamic acid-15N
287484-35-9
(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]pentanedioic acid
823835-41-2
L-Glutamic acid, N-[[5-[[(2-amino-3, 4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-2-pyrimidinyl]carbonyl]-, monohydrate
54246-73-0
L-Glutamic acid,N-[4-[[[(2,4-diamino-6-pteridinyl)methyl]methylamino]methyl]benzoyl]-, disodiumsalt (9CI)
65546-01-2
(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-methylbutanoyl]amino]pentanedioic acid
586356-56-1
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
Fonazine, (S)-
1254332-76-7
(3-((1-benzylpiperidin-4-yl)methyl)-3H-imidazo[4,5-b]pyridin-2-yl)methanol
1420904-32-0
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4